查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786820

宠物骨关节炎的全球市场，规模，占有率，趋势，产业分析报告:动物，各产品，各给药途径，各最终用途，各地区 - 市场预测，2025年～2034年

Companion Animal Osteoarthritis Market Size, Share, Trend, Industry Analysis Report By Animal (Canine, Equine, Feline), By Product, By Route of Administration, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，伴侣动物骨关节炎市场规模将达到 184.5 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

伴侣动物骨关节炎市场满足了宠物（尤其是犬猫）对退化性关节疾病医疗解决方案日益增长的需求。骨关节炎是一种慢性进行性疾病，是老年动物活动能力下降和疼痛的主要原因。随着宠物主人意识的增强、兽医咨询的增加以及诊断能力的提高，该市场正在蓬勃发展。成长的动力源自于药物製剂的进步，包括长效注射剂和消炎药，这些进步提高了治疗依从性和宠物的生活品质。

兽医正在整合再生疗法，例如富血小板血浆 (PRP) 和干细胞应用，以控制发炎并促进关节修復。对早期介入和多方面疼痛管理的日益重视，正在影响包括药物、营养补充剂和物理復健在内的联合疗法的发展。市场参与者正在回应对非侵入性治疗方案和针对不同风险状况的犬种特定解决方案的需求。监测活动量和活动能力的数位工具正在成为辅助技术，能够更好地追踪治疗并提高护理人员的参与度。预防医学领域的机会持续扩大，尤其是在关节健康补充剂和老年宠物健康计划的製定方面。宠物人性化趋势日益增长，促使製造商优先考虑安全性、适口性和实证有效性。不断发展的兽医指南以及兽医诊所和製药公司之间的合作，正在推动产品创新和临床应用。

伴侣动物骨关节炎市场报告重点

按产品类型划分，生物製剂领域预计将在2024年占约54%的收入占有率，因为它能够针对骨关节炎的根本原因，而不仅仅是缓解症状。

按动物类型划分，由于骨关节炎发生率高，尤其是在老年大型动物中，因此预计犬类领域将在2024年占最大的收入占有率。

预计2024年北美将占最大的收入占有率，因为该地区宠物医疗保健支出高、兽医基础设施先进，并且人们对伴侣动物慢性关节疾病的认识也越来越高。

受宠物拥有量增加、中等收入群体收入增加以及动物健康意识增强的推动，亚太地区伴侣动物骨关节炎市场预计将在2025年至2034年间大幅增长。

主要的全球公司包括勃林格殷格翰国际有限公司、诗华製药、Dechra Pharmaceuticals PLC.、礼来公司、Eltech K-Laser s.r.l.、NexGen Pharmaceuticals、Norbrook、Vetoquinol、维克和硕腾。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 宠物骨关节炎市场洞察

  • 市场概述
  • 宠物骨关节炎市场动态
    • 促进因素和机会
      • 宠物拥有量增加及人性化
      • 兽医骨科护理的成长
    • 限制因素与课题
      • 高昂的治疗费用
  • PESTEL分析
  • 宠物骨关节炎市场电力评估趋势
  • 价值链分析

第5章 宠物骨关节炎市场:各产品

  • 主要调查结果
  • 简介
  • 生物製药
  • 粘性补充品
  • 医药品
  • 营养补充品

第6章 宠物骨关节炎市场:动物

  • 主要调查结果
  • 简介
  • 狗
  • 马
  • 猫
  • 其他

第7章 宠物骨关节炎市场:各给药途径

  • 主要调查结果
  • 简介
  • 口服
  • 注射
  • 其他

第8章 宠物骨关节炎市场:各最终用途

  • 主要调查结果
  • 简介
  • 动物医院/诊所
  • 电子商务
  • 其他

第9章 宠物骨关节炎市场:各地区

  • 主要调查结果
  • 简介
    • 宠物骨关节炎市场分析:各地区，2020年～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各:动物，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 北美:各给药途径，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各动物，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 欧洲:各给药途径，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各动物，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 亚太地区:各给药途径，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各动物，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 中东·非洲:各给药途径，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各动物，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 南美:各给药途径，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC.
  • Elanco
  • Eltech K-Laser s.r.l.
  • NexGen Pharmaceuticals
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis
Product Code: PM6060

The companion animal osteoarthritis market size is expected to reach USD 18.45 billion by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Osteoarthritis Market Size, Share, Trend, Industry Analysis Report By Animal (Canine, Equine, Feline), By Product, By Route of Administration, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion animal osteoarthritis market addresses the growing demand for medical solutions targeting degenerative joint conditions in pets, particularly dogs and cats. Osteoarthritis, a chronic and progressive disease, is a leading cause of mobility loss and pain in aging animals. The market is gaining momentum due to increasing awareness among pet owners, a rise in veterinary consultations, and improved diagnostic capabilities. Growth is supported by advancements in pharmaceutical formulations, including long-acting injectable and anti-inflammatory medications that enhance treatment compliance and quality of life for pets.

Veterinarians are integrating regenerative therapies such as platelet-rich plasma (PRP) and stem cell applications to manage inflammation and promote joint repair. Increasing emphasis on early intervention and multimodal pain management is influencing the development of combination therapies involving drugs, dietary supplements, and physical rehabilitation. Market participants are responding to demand for noninvasive options and breed-specific solutions that address varying risk profiles. Digital tools for monitoring activity levels and mobility are emerging as supportive technologies, enabling better treatment tracking and caregiver engagement. Opportunities continue to grow in preventive care, particularly in the development of joint health supplements and wellness plans for senior pets. The rising trend of pet humanization is pushing manufacturers to prioritize safety, palatability, and evidence-based efficacy. Evolving veterinary guidelines and collaboration between veterinary practices and pharmaceutical companies are driving product innovation and clinical adoption.

Companion Animal Osteoarthritis Market Report Highlights

By product, the biologics segment accounted for ~54% of the revenue share in 2024 due to their ability to target the underlying causes of osteoarthritis rather than just alleviating symptoms.

Based on animal, the canine segment held the largest revenue share in 2024 due to the high incidence of osteoarthritis, particularly in aging and large-breed animals.

In 2024, North America accounted for the largest revenue share due to high pet healthcare spending, advanced veterinary infrastructure, and strong awareness of chronic joint conditions in companion animals.

The Asia Pacific companion animal osteoarthritis market is expected to grow significantly from 2025 to 2034 due to rising pet adoption, expanding middle-class income, and increasing awareness of animal health.

A few global key players include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Elanco, Eltech K-Laser s.r.l., NexGen Pharmaceuticals, Norbrook, Vetoquinol, Virbac, and Zoetis.

Polaris Market Research has segmented the companion animal osteoarthritis market report on the basis of product, animal, route of administration, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Monoclonal Antibodies (mAb)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

Nutritional Supplements

By Animal Outlook (Revenue, USD Billion, 2020-2034)

Canine

Equine

Feline

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral

Injectable

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Veterinary Hospitals/Clinics

E-commerce

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Companion Animal Osteoarthritis Market Insights

  • 4.1. Companion Animal Osteoarthritis Market - Market Snapshot
  • 4.2. Companion Animal Osteoarthritis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Pet Ownership and Humanization
      • 4.2.1.2. Growth in Veterinary Orthopaedic Treatments
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Companion Animal Osteoarthritis Market Power Rating Trends
  • 4.6. Value Chain Analysis

5. Companion Animal Osteoarthritis Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Companion Animal Osteoarthritis Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Biologics
    • 5.3.1. Companion Animal Osteoarthritis Market, by Biologics, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Stem Cells
      • 5.3.2.1. Companion Animal Osteoarthritis Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Platelet-Rich Plasma (PRP)
      • 5.3.3.1. Companion Animal Osteoarthritis Market, by Platelet-Rich Plasma (PRP), by Region, 2020-2034 (USD Billion)
    • 5.3.4. Monoclonal Antibodies (mAb)
      • 5.3.4.1. Companion Animal Osteoarthritis Market, by Monoclonal Antibodies (mAb), by Region, 2020-2034 (USD Billion)
    • 5.3.5. Other Biologics
      • 5.3.5.1. Companion Animal Osteoarthritis Market, by Other Biologics, by Region, 2020-2034 (USD Billion)
  • 5.4. Viscosupplements
    • 5.4.1. Companion Animal Osteoarthritis Market, by Viscosupplements, by Region, 2020-2034 (USD Billion)
  • 5.5. Pharmaceuticals
    • 5.5.1. Companion Animal Osteoarthritis Market, by Pharmaceuticals, by Region, 2020-2034 (USD Billion)
    • 5.5.2. Steroids
      • 5.5.2.1. Companion Animal Osteoarthritis Market, by Steroids, by Region, 2020-2034 (USD Billion)
    • 5.5.3. NSAIDS
      • 5.5.3.1. Companion Animal Osteoarthritis Market, by NSAIDS, by Region, 2020-2034 (USD Billion)
    • 5.5.4. Others
      • 5.5.4.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
  • 5.6. Nutritional Supplements
    • 5.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

6. Companion Animal Osteoarthritis Market, by Animal

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 6.3. Canine
    • 6.3.1. Companion Animal Osteoarthritis Market, by Canine, by Region, 2020-2034 (USD Billion)
  • 6.4. Equine
    • 6.4.1. Companion Animal Osteoarthritis Market, by Equine, by Region, 2020-2034 (USD Billion)
  • 6.5. Feline
    • 6.5.1. Companion Animal Osteoarthritis Market, by Feline, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

7. Companion Animal Osteoarthritis Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Oral
    • 7.3.1. Companion Animal Osteoarthritis Market, by Oral, by Region, 2020-2034 (USD Billion)
  • 7.4. Injectable
    • 7.4.1. Companion Animal Osteoarthritis Market, by Injectable, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

8. Companion Animal Osteoarthritis Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Veterinary Hospitals/Clinics
    • 8.3.1. Companion Animal Osteoarthritis Market, by Veterinary Hospitals/Clinics, by Region, 2020-2034 (USD Billion)
  • 8.4. E-commerce
    • 8.4.1. Companion Animal Osteoarthritis Market, by E-commerce, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

9. Companion Animal Osteoarthritis Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Companion Animal Osteoarthritis Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Companion Animal Osteoarthritis Market - North America
    • 9.3.1. North America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.3.3. North America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.4. North America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.5. Companion Animal Osteoarthritis Market - US
      • 9.3.5.1. US: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.6. Companion Animal Osteoarthritis Market - Canada
      • 9.3.6.1. Canada: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4. Companion Animal Osteoarthritis Market - Europe
    • 9.4.1. Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.5. Companion Animal Osteoarthritis Market - UK
      • 9.4.5.1. UK: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.6. Companion Animal Osteoarthritis Market - France
      • 9.4.6.1. France: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.7. Companion Animal Osteoarthritis Market - Germany
      • 9.4.7.1. Germany: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.8. Companion Animal Osteoarthritis Market - Italy
      • 9.4.8.1. Italy: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.9. Companion Animal Osteoarthritis Market - Spain
      • 9.4.9.1. Spain: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.10. Companion Animal Osteoarthritis Market - Netherlands
      • 9.4.10.1. Netherlands: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.11. Companion Animal Osteoarthritis Market - Russia
      • 9.4.11.1. Russia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.12. Companion Animal Osteoarthritis Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5. Companion Animal Osteoarthritis Market - Asia Pacific
    • 9.5.1. Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.5. Companion Animal Osteoarthritis Market - China
      • 9.5.5.1. China: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.6. Companion Animal Osteoarthritis Market - India
      • 9.5.6.1. India: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.7. Companion Animal Osteoarthritis Market - Malaysia
      • 9.5.7.1. Malaysia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.8. Companion Animal Osteoarthritis Market - Japan
      • 9.5.8.1. Japan: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.9. Companion Animal Osteoarthritis Market - Indonesia
      • 9.5.9.1. Indonesia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.10. Companion Animal Osteoarthritis Market - South Korea
      • 9.5.10.1. South Korea: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.11. Companion Animal Osteoarthritis Market - Australia
      • 9.5.11.1. Australia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.12. Companion Animal Osteoarthritis Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6. Companion Animal Osteoarthritis Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.5. Companion Animal Osteoarthritis Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.6. Companion Animal Osteoarthritis Market - UAE
      • 9.6.6.1. UAE: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.7. Companion Animal Osteoarthritis Market - Israel
      • 9.6.7.1. Israel: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.8. Companion Animal Osteoarthritis Market - South Africa
      • 9.6.8.1. South Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.9. Companion Animal Osteoarthritis Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7. Companion Animal Osteoarthritis Market - Latin America
    • 9.7.1. Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.5. Companion Animal Osteoarthritis Market - Mexico
      • 9.7.5.1. Mexico: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.6. Companion Animal Osteoarthritis Market - Brazil
      • 9.7.6.1. Brazil: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.7. Companion Animal Osteoarthritis Market - Argentina
      • 9.7.7.1. Argentina: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.8. Companion Animal Osteoarthritis Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Boehringer Ingelheim International GmbH
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Ceva
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Dechra Pharmaceuticals PLC.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Elanco
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eltech K-Laser s.r.l.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. NexGen Pharmaceuticals
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Norbrook
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Vetoquinol
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Virbac
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Zoetis
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 2 Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 3 Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 5 North America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 6 North America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 7 North America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 8 North America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 US: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 10 US: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 11 US: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 12 US: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 13 Canada: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 15 Canada: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 Canada: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 17 Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 19 Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 20 Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 21 UK: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 22 UK: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 23 UK: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 24 UK: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 25 France: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 26 France: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 27 France: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 France: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 Germany: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 31 Germany: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 32 Germany: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 33 Italy: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 35 Italy: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 36 Italy: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 37 Spain: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 39 Spain: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Spain: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 45 Russia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 47 Russia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 48 Russia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 57 China: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 58 China: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 59 China: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 60 China: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 61 India: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 62 India: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 63 India: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 India: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Japan: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 71 Japan: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 72 Japan: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 77 South Korea: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 79 South Korea: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 80 South Korea: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 81 Australia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 83 Australia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 84 Australia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 97 UAE: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 99 UAE: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 100 UAE: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 101 Israel: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 103 Israel: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 104 Israel: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 105 South Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 107 South Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 108 South Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 113 Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 115 Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 116 Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 117 Mexico: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 119 Mexico: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 120 Mexico: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 121 Brazil: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 123 Brazil: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 124 Brazil: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 125 Argentina: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 127 Argentina: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 128 Argentina: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Companion Animal Osteoarthritis Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Companion Animal Osteoarthritis Market, By Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Animal
  • Figure 9. Companion Animal Osteoarthritis Market, By Animal, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Companion Animal Osteoarthritis Market, by End Use, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Route of Administration
  • Figure 13. Companion Animal Osteoarthritis Market, by Route of Administration, 2024 & 2034 (USD Billion)